Healthcare innovation cannot be validated in theory alone.
Before hospitals, healthcare providers, investors, or public authorities adopt a new solution, they need evidence that it works within real healthcare environments.
The DigiCare Innovation Accelerator gives startups access to specialised European HealthTech testbeds where innovations can be explored and refined under realistic conditions.
Working together with clinicians, researchers, patients, caregivers, and technology experts, startups gain valuable insights into usability, interoperability, workflow integration, user acceptance, and implementation challenges.
The result is stronger evidence, lower market risk, improved investment readiness, and greater confidence for future deployment across European healthcare systems.
We are looking for innovative startups that:
✔ develop HealthTech or Digital Health solutions;
✔ have reached Technology Readiness Level (TRL) 4 or above;
✔ are at pre-seed or seed stage;
✔ are committed to participating throughout the programme;
✔ are ready to validate their technology within real healthcare environments.
• Digital Health
• Artificial Intelligence
• Medical Technologies
• Digital Therapeutics
• Oncology
• Mental Health
• Healthy Ageing
• Remote Monitoring
• Community Care
• Smart Living
By the end of the programme, participants will have developed:
✔ Validation evidence
✔ Refined value proposition
✔ Regulatory awareness
✔ Go-to-market strategy
✔ Investor-ready Pitch Deck
✔ Funding roadmap
✔ Strategic partnerships
✔ European business network
✔ Scaling strategy
Yes. Participation is free for selected startups.
The accelerator does not provide direct funding. Instead, it prepares startups for investment opportunities, strategic partnerships, and future funding.
The DigiCare team will identify the testbed that best matches your technology and validation needs.
Yes. Teams are encouraged to participate together, although one representative should be responsible for strategic decisions.
Participants become part of the DigiCare Innovation community and continue building collaborations with universities, healthcare organisations, investors, and innovation partners across Europe.